In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
All content for St John's DermAcademy Podcast is the property of St John's DermAcademy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
In this episode we discuss… The indications, benefits and pitfalls of the following treatments for acne scaring: · Surgical procedures including subcision and punch excision · Procedures such as microneedling, chemical peels and soft tissue augmentation · Ablative and non-ablative lasers Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.
St John's DermAcademy Podcast
In this episode our host Dr Sarah Drummond speaks with Professor Catherine Smith and Dr Andrew Pink about eczema therapeutics: • The use of JAK inhibitors licensed for use in managing eczema including their mechanism of action, monitoring requirements and potential side effects. • Newer agents currently under investigation. • The BEACON trial Recorded: 19 March 2024 For more information, visit: www.stjohnsdermacademy.com/podcasts Disclaimer: The information on our ...
